Option Care Health, Inc. (NASDAQ:OPCH) Shares Sold by Victory Capital Management Inc.

Victory Capital Management Inc. decreased its stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 6.6% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 1,984,306 shares of the company's stock after selling 141,127 shares during the quarter. Victory Capital Management Inc. owned 1.21% of Option Care Health worth $69,351,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also recently bought and sold shares of OPCH. JPMorgan Chase & Co. grew its position in Option Care Health by 29.6% in the fourth quarter. JPMorgan Chase & Co. now owns 1,511,403 shares of the company's stock valued at $35,065,000 after acquiring an additional 344,875 shares during the period. Compass Wealth Management LLC increased its holdings in shares of Option Care Health by 8.9% in the first quarter. Compass Wealth Management LLC now owns 166,078 shares of the company's stock worth $5,804,000 after acquiring an additional 13,600 shares in the last quarter. Bessemer Group Inc. grew its holdings in shares of Option Care Health by 62.3% during the first quarter. Bessemer Group Inc. now owns 1,560 shares of the company's stock worth $54,000 after buying an additional 599 shares in the last quarter. Principal Financial Group Inc. lifted its holdings in Option Care Health by 1.4% during the 1st quarter. Principal Financial Group Inc. now owns 485,871 shares of the company's stock worth $16,981,000 after purchasing an additional 6,616 shares during the last quarter. Finally, Wealth Enhancement Advisory Services LLC increased its stake in Option Care Health by 25.7% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 8,274 shares of the company's stock worth $289,000 after acquiring an additional 1,691 shares during the period. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of brokerages have commented on OPCH. Barrington Research reissued an "outperform" rating and set a $38.00 price objective on shares of Option Care Health in a report on Thursday, July 10th. UBS Group raised Option Care Health from a "neutral" rating to a "buy" rating and raised their price objective for the company from $38.00 to $40.00 in a research note on Wednesday, April 30th. Finally, JMP Securities reiterated a "market outperform" rating and set a $36.00 target price on shares of Option Care Health in a report on Wednesday, June 18th. One investment analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $35.50.

Option Care Health Trading Down 1.1%

Shares of NASDAQ OPCH traded down $0.31 during mid-day trading on Monday, hitting $29.17. The company's stock had a trading volume of 906,660 shares, compared to its average volume of 1,827,036. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.54 and a quick ratio of 1.02. The stock has a market cap of $4.78 billion, a price-to-earnings ratio of 21.52, a price-to-earnings-growth ratio of 1.78 and a beta of 0.73. The company's fifty day simple moving average is $31.58 and its 200-day simple moving average is $31.73. Option Care Health, Inc. has a one year low of $21.39 and a one year high of $35.53.

Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its earnings results on Tuesday, April 29th. The company reported $0.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.04. The firm had revenue of $1.33 billion during the quarter, compared to analyst estimates of $1.26 billion. Option Care Health had a return on equity of 16.90% and a net margin of 4.12%. The business's revenue was up 16.3% compared to the same quarter last year. During the same period last year, the firm posted $0.26 EPS. On average, sell-side analysts anticipate that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.